Morgan Stanley maintained an overweight rating on D-Mart with a target price of Rs 4471. The Q3 operational metrics improve further, however, the pace of store additions needs to pick up, it said.
The standalone revenue from operations for quarter ended December 31, 2023 given above is subject to limited review by the statutory auditors of the company, Avenue Supermarts added.
Investec maintained a buy rating on Orchid Pharma with a target price of Rs 800. The company is set for strong growth over the next 3 years. The new management continues to execute the turnaround strategy well. It sees a strong 35%+ EBITDA CAGR over FY23-26 for the base biz (ex-PLI).
Among the top 10 Self-Made Entrepreneurs study are Binny and Sachin Bansal of Flipkart, Vijay Shekhar Sharma of Paytm, Kunal Shah of Cred, Deepinder Goyal of Zomato, and the Kamath brothers of Zerodha.